Loading patent…
AssigneeBioview Ltd.
InventorsMichal Daniely, Lea Madi, Tal Kaplan, Boaz Pal, Yuval Harari, Tanweer M. Zaidi, Ricardo L. Fernandez, Jinping Zhang, Ruth Katz
Estimating the term…
Provided is a method of identifying a genetically abnormal cell in a sputum sample, the method comprising: (a) staining a sputum sample using a morphological stain so as to identify a lower airway tract cell or lung cell in the sputum sample; and (b) staining the sputum sample using fluorescent in situ hybridization (FISH) so as to identify in the lower airway tract cell or lung cell a genetic abnormality in at least one of human chromosome 3p22.1 and 10q22-23, thereby identifying the genetically abnormal cell in the sputum sample. Also provided are methods and kits of diagnosing lung cancer by detecting a presence of genetically abnormal cells above a predetermined threshold in a sputum sample.
A method of identifying a genetically abnormal cell in a sputum sample, the method comprising:
A method of diagnosing lung cancer in a subject comprising:
A method of diagnosing lung cancer in a subject, comprising:
A kit for diagnosing lung cancer, the kit comprising a morphological stain and a FISH probe specific for human chromosome 3p22.1 and/or 10q22-23.
Dependencies are inferred from the claim text.